Last Posted: Dec 07, 2019
- How Genetic Testing Saved One Woman's Life
K Kosko, Cure Magazine, December 6, 2019 - Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico.
Dutil Julie et al. Scientific reports 2019 Nov 9(1) 17769 - Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).
Ruiz de Sabando Ainara et al. BMC cancer 2019 Nov 19(1) 1145 - Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea.
Seo Jun Hyeong et al. Obstetrics & gynecology science 2019 Nov 62(6) 411-419 - Retesting of women who are negative for a BRCA1 and BRCA2 mutation using a 20-gene panel.
Lerner-Ellis Jordan et al. Journal of medical genetics 2019 Nov - Mainstreamed genetic testing in ovarian cancer: patient experience of the testing process.
McLeavy Laura et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2019 Nov - Counseling young women with early breast cancer on fertility preservation.
Ter Welle-Butalid M E Elena et al. Journal of assisted reproduction and genetics 2019 Nov - Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians.
Dekanek Erin W et al. Journal of genetic counseling 2019 Nov - Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas.
Dowson Cassandra B et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2019 Nov - Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
Elsayegh Nisreen et al. Cancer medicine 2018 7(6) 2718-2726
.png)
No hay comentarios:
Publicar un comentario